# COMBOPROFEN for Treatment of Muscular Pain Associated With Delayed Onset Muscle Soreness (DOMS)

> **NCT03223519** · PHASE2 · COMPLETED · sponsor: **Spherium Biomed** · enrollment: 74 (actual)

## Conditions studied

- Delayed Onset Muscle Soreness, DOMS

## Interventions

- **DRUG:** Comboprofen
- **DRUG:** Placebo
- **DRUG:** Ibuprofen
- **DRUG:** Magnesium
- **DRUG:** Vitamin C

## Key facts

- **NCT ID:** NCT03223519
- **Lead sponsor:** Spherium Biomed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-12
- **Primary completion:** 2017-11-24
- **Final completion:** 2017-11-28
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2018-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03223519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03223519, "COMBOPROFEN for Treatment of Muscular Pain Associated With Delayed Onset Muscle Soreness (DOMS)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03223519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*